The majority of women at high risk of developing breast cancer decide against prophylactic treatment with tamoxifen, suggest findings of a new study funded by Cancer Research UK and published in Breast Cancer Research and Treatment.
Read More
The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
Read More
The National Institute for Health and Care Excellence is now backing the use of three medicines to prevent breast cancer in women with a family history of the disease, adding anastrozole to the mix for the first time.
Read More
